Page last updated: 2024-09-03

mk 0663 and Peptic Ulcer Perforation

mk 0663 has been researched along with Peptic Ulcer Perforation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Evans, JK; Harper, S; Hunt, RH; Lee, M; Oxenius, B; Quan, H; Watson, DJ; Yu, C	1

Trials

1 trial(s) available for mk 0663 and Peptic Ulcer Perforation

Article	Year
The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events. The American journal of gastroenterology, 2003, Volume: 98, Issue:8 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Double-Blind Method; Endoscopy; Etoricoxib; Female; Gastrointestinal Hemorrhage; Humans; Ibuprofen; Incidence; Isoenzymes; Male; Membrane Proteins; Meta-Analysis as Topic; Middle Aged; Peptic Ulcer; Peptic Ulcer Perforation; Prostaglandin-Endoperoxide Synthases; Pyridines; Sulfones; Treatment Outcome	2003

Article

Year

The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events.

The American journal of gastroenterology, 2003, Volume: 98, Issue:8

Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Double-Blind Method; Endoscopy; Etoricoxib; Female; Gastrointestinal Hemorrhage; Humans; Ibuprofen; Incidence; Isoenzymes; Male; Membrane Proteins; Meta-Analysis as Topic; Middle Aged; Peptic Ulcer; Peptic Ulcer Perforation; Prostaglandin-Endoperoxide Synthases; Pyridines; Sulfones; Treatment Outcome

2003